title: The flavonoid quercetin: possible solution for anthracycline-induced cardiotoxicity and multidrug resistance.
abstract: Anthracycline chemotherapy is often used in the treatment of various malignancies. Its application, however, encounters several limitations due to development of serious side effects, mainly cardiotoxicity and may be ineffective due to multidrug resistance (MDR). Many different compounds have been evaluated as poorly effective in the protection against anthracycline side effects and in the prevention from MDR. Thus, continuous investigational efforts are necessary to find valuable protectants and the flavonoid quercetin (Q) seems to be a promising candidate. It is present in relatively high amounts in a human diet and the lack of its toxicity, including genotoxicity has been confirmed. The structure of Q favours its high antioxidant activity, the potential to inhibit the activity of oxidative enzymes and to interact with membrane transporter proteins responsible for development of MDR, e.g. P-glycoprotein. Furthermore, Q can influence cellular signalling and gene expression, and thus, alter response to exogenous genotoxicants and oxidative stress in normal cells. It accounts for its chemopreventive and anticancer properties. Overall, these properties might indicate the possibility of application of Q as cardioprotectant during anthracycline chemotherapy. Moreover, numerous biological properties displayed by Q might possibly result in the reversal of MDR in tumour cells and improve the efficacy of chemotherapy. However, these beneficial effects towards anthracycline-induced complications of chemotherapy have to be further explored and confirmed both in animal and clinical studies. Concurrently, investigations aimed at improvement of the bioavailability of Q and further elucidation of its metabolism after application in combination with anthracyclines are needed.
authors.affiliation: Department of Molecular Biophysics, Faculty of Biology and Environmental Protection, University of Łódź, Łódź, Poland. Electronic address: jczepas@biol.uni.lodz.pl.
authors.forename: Jan
authors.initials: J
authors.lastname: Czepas
authors.affiliation: Department of Molecular Biophysics, Faculty of Biology and Environmental Protection, University of Łódź, Łódź, Poland.
authors.forename: Krzysztof
authors.initials: K
authors.lastname: Gwoździński
mesh_terms: D000818:Animals; D018943:Anthracyclines / Q000037:antagonists & inhibitors / Q000633:toxicity*; D054715:Cardiotoxins / Q000633:toxicity*; D018432:Drug Resistance, Multiple / Q000187:drug effects* / Q000502:physiology; D005419:Flavonoids / Q000737:chemistry / Q000494:pharmacology*; D006801:Humans; D018384:Oxidative Stress / Q000187:drug effects / Q000502:physiology; D011794:Quercetin / Q000737:chemistry / Q000494:pharmacology*
chemical_list: D018943:Anthracyclines; D054715:Cardiotoxins; D005419:Flavonoids; D011794:Quercetin
keywords: Anthracycline; Antioxidant; Cardiotoxicity; Flavonoid; Multidrug resistance; Quercetin